Immune System Key Ltd.
  • Home
  • News & Events
  • Science And R&D
    • Nerofe Pipeline
    • Technology
    • Nerofe Mode of Action
    • Phase I Results
    • First Success Story
  • Company Description
    • Team
  • Contact Us
Immune System Key Ltd.
  • Home
  • News & Events
  • Science And R&D
    • Nerofe Pipeline
    • Technology
    • Nerofe Mode of Action
    • Phase I Results
    • First Success Story
  • Company Description
    • Team
  • Contact Us

MGH_HARVARD_LOGO

  • Home
  • MGH_HARVARD_LOGO

MGH_HARVARD_LOGO

October 27, 2019

Joel Ohana2019-10-27T17:25:25+00:0027 Oct|

Related Posts

  • Georgetown University at Washington DC has signed a contract with ISK to run a clinical trial with patients with mtKRAS tumors

    February 17, 2022

    The prestigious medical center Georgetown University at Washington DC has sign a contract with ISK to run a clinical trial with patients with mtKRAS pancreas and colon cancers.

  • PHASE 1B/2A Clinical trial started

    April 13, 2021
  • Cooperation with Harvard Medical School (MGH)

    October 27, 2019

    ISK has signed an agreement for cooperation with Harvard Medical School for drug development to treat neurodegenerative diseases

  • Permalink Gallery

    Georgetown University at Washington DC has signed a contract with ISK to run a clinical trial with patients with mtKRAS tumors

  • Usylvester
    Permalink Gallery

    PHASE 1B/2A Clinical trial started

  • Permalink Gallery

    Cooperation with Harvard Medical School (MGH)

Recent Posts

  • Phase II update – A second patient (92 years old) had a strong reduction in blasts in the bone marrow
  • Update from AML human trial in Miami
  • Georgetown University at Washington DC has signed a contract with ISK to run a clinical trial with patients with mtKRAS tumors
  • PHASE 1B/2A Clinical trial started
  • ISK received the FDA’s approval to start Phase 1b/2a with AML patients

Tags

AML AML drug cancer Clinical Trial human trial MDS Nerofe phase II research Treatment

Categories

  • News
  • About
  • News & Events
  • Contact Us
  • Disclaimer
Immune System Key (ISK) Ltd. Hava'ad Haleumi 21, Jerusalem 91160, Israel Tel: +972-50-2597031/2
logo
Copyright © 2015 ISK Ltd.